Uncertainty continues over steroids for sepsis
Corticosteroids have a long history in the treatment of septic shock. The evidence has gone first one way, then the other, with dedicated critical care doctors not far behind, says an editorial (pp 2388-90). In 2002, the United States briefly ran out of hydrocortisone after an unusually rapid and enthusiastic response to a positive French trial of low dose therapy. More recently, longer courses of low doses have fallen out of favour. Current guidelines sit on the fence with “suggestions” rather than recommendations, citing weaknesses in the evidence for their uncertainty.
The latest addition to this messy situation is a meta-analysis of all potentially relevant trials, including 12 trials that looked specifically at the benefits of at least five days of low dose corticosteroids. This low dose strategy was associated with lower mortality at 28 days than a high dose approach (236/629 (37.5%) v 264/599 (44.1%); risk ratio 0.84, 95% confidence interval 0.72 to 0.97).⇑
The authors of this study and the authors of the editorial agree this subanalysis cannot be the final word, however. Other analyses of all trials (short and long duration of treatment; high and low doses) failed to find conclusive evidence of benefit.
Clearly, health professionals caring for patients with severe sepsis and septic shock will have to live with uncertainty for at least a little while longer, says the editorial. Doctors should embrace this uncertainty, then share it with patients and their relatives. For now, “the final decision rests squarely on those at the bedside.”
Six months of androgen suppression is not enough for men with locally advanced prostate cancer
Long term androgen suppression prolongs survival in men who have had radiotherapy for locally advanced prostate cancer. Treatment with analogues of luteinising hormone releasing hormone causes unpleasant side effects though, including poor sex drive, hot flushes, heart attacks, and fractures. Can men safely stop androgen suppression after just six …
Sign in
Personal subscribers, sign in here:
Article access
Article access for 1 day
Purchase this article for £20 $30 €32*
The PDF version can be downloaded as your personal record
CiteULike
Connotea
Del.icio.us
Digg
Facebook
Reddit
Technorati
Twitter
Stumbleupon
Rapid responses
Latest Responses
The decline in the breast cancer incidence is 1.2% and it is not significant.
Published 10 February 2012
'twas ever thus
Published 10 February 2012
The value of historic human remains
Published 10 February 2012
In Praise of British Literature
Published 10 February 2012
Is real shared decision making possible?
Published 10 February 2012
Most responses
Does anyone understand the government’s plan for the NHS? (17 responses)
Published 17 Jan 2012
Bad medicine: medical nutrition (15 responses)
Published 18 Jan 2012
Shared decision making: really putting patients at the centre of healthcare (7 responses)
Published 27 Jan 2012
Why legislation is necessary for my health reforms (7 responses)
Published 1 Feb 2012
Search for evidence goes on (5 responses)
Published 17 Jan 2012